EOFlow Q1 2026 Revenue Down 30% YoY
이오플로우
294090
Signal Score
Historical Avg Return (5d)
-0.18%
Data Coverage
100%n=3385
Risk-adjusted indicator based on 3385 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Q1 2026 Revenue: 3.67B KRW
- • Q1 2025 Revenue: 5.241B KRW
- • Revenue Decrease (YoY): 1.571B KRW (-30.0%)
- • Research & Development Expenses (Q1 2026): 2.096B KRW
- • R&D to Revenue Ratio (Q1 2026): 57%
AI Analysis Summary
EOFlow Co., Ltd. reported a significant 30.0% year-over-year decrease in Q1 2026 revenue, falling to 3.67 billion KRW from 5.241 billion KRW in Q1 2025. This decline is primarily attributed to business environment changes and operational constraints stemming from an ongoing lawsuit with Insulet, leading to reduced new user acquisition and increased existing user churn. Despite the revenue drop, the company maintained substantial R&D investment, with Q1 2026 R&D expenses at 2.096 billion KRW, representing 57% of revenue. The company plans to recover revenue by normalizing global sales activities once the lawsuit uncertainty is resolved. The overall financial impact is negative due to the substantial revenue decline and ongoing legal challenges.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.